Pharmacokinetic interaction study [Regulatives / Guidelines]

posted by nobody – 2016-05-20 11:40 (3194 d 08:38 ago) – Posting: # 16343
Views: 3,287

I would support this opinion (at least for EU), as the EMA DDI Guideline as of 2012 does not require formal BE testing. Why should this be more rigid for new FDCs?

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,381 posts in 4,914 threads, 1,663 registered users;
47 visitors (0 registered, 47 guests [including 9 identified bots]).
Forum time: 19:18 CET (Europe/Vienna)

Science is built up with facts, as a house is with stones.
But a collection of facts is no more a science
than a heap of stones is a house.    Henri Poincaré

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5